388 related articles for article (PubMed ID: 31082822)
41. Chronic Rhinosinusitis-Could Phenotyping or Endotyping Aid Therapy?
Bayar Muluk N; Cingi C; Scadding GK; Scadding G
Am J Rhinol Allergy; 2019 Jan; 33(1):83-93. PubMed ID: 30353741
[TBL] [Abstract][Full Text] [Related]
42. The role of biologics in chronic rhinosinusitis: a systematic review.
Iqbal IZ; Kao SS; Ooi EH
Int Forum Allergy Rhinol; 2020 Feb; 10(2):165-174. PubMed ID: 31869863
[TBL] [Abstract][Full Text] [Related]
43. Biologicals and Endoscopic Sinus Surgery for Severe Uncontrolled Chronic Rhinosinusitis With Nasal Polyps: An Economic Perspective.
van der Lans RJL; Hopkins C; Senior BA; Lund VJ; Reitsma S
J Allergy Clin Immunol Pract; 2022 Jun; 10(6):1454-1461. PubMed ID: 35231626
[TBL] [Abstract][Full Text] [Related]
44. Oral Therapeutics for Rhinosinusitis with Nasal Polyposis.
Thomas AJ; Alt JA
Adv Otorhinolaryngol; 2016; 79():138-47. PubMed ID: 27466856
[TBL] [Abstract][Full Text] [Related]
45. Treatment options for chronic rhinosinusitis with nasal polyps.
Wallace DV
Allergy Asthma Proc; 2021 Nov; 42(6):450-460. PubMed ID: 34871152
[No Abstract] [Full Text] [Related]
46. Monoclonal Antibodies for the Treatment of Nasal Polyps.
Willson TJ; Naclerio RM; Lee SE
Immunol Allergy Clin North Am; 2017 May; 37(2):357-367. PubMed ID: 28366482
[TBL] [Abstract][Full Text] [Related]
47. Effects of Reslizumab on Asthma Outcomes in a Subgroup of Eosinophilic Asthma Patients with Self-Reported Chronic Rhinosinusitis with Nasal Polyps.
Weinstein SF; Katial RK; Bardin P; Korn S; McDonald M; Garin M; Bateman ED; Hoyte FCL; Germinaro M
J Allergy Clin Immunol Pract; 2019 Feb; 7(2):589-596.e3. PubMed ID: 30193936
[TBL] [Abstract][Full Text] [Related]
48. Definition of severity and treatment response in chronic rhinosinusitis with nasal polyps: a Delphi study among French experts.
Carsuzaa F; Fath L; Fieux M; Bartier S; de Bonnecaze G; Rumeau C; Michel J; Papon JF; Alexandru M; Favier V
Expert Rev Clin Immunol; 2023; 19(8):1005-1011. PubMed ID: 37327360
[TBL] [Abstract][Full Text] [Related]
49. Otitis media in severe asthma associated with chronic rhinosinusitis with nasal polyps: a new therapeutic target for biologics.
Bartier S; Béquignon E; Thibaut de Ménonville C; Verillaud B; Evrard D; Léger M; Papon JF; Coste A; Taillé C
J Asthma; 2023 Jan; 60(1):139-144. PubMed ID: 35073225
[No Abstract] [Full Text] [Related]
50. Which Is the Best Biologic for Nasal Polyps: Dupilumab, Omalizumab, or Mepolizumab? A Network Meta-Analysis.
Wu Q; Zhang Y; Kong W; Wang X; Yuan L; Zheng R; Qiu H; Huang X; Yang Q
Int Arch Allergy Immunol; 2022; 183(3):279-288. PubMed ID: 34607329
[TBL] [Abstract][Full Text] [Related]
51. Guideline for the use of immunobiologicals in chronic rhinosinusitis with nasal polyps (CRSwNP) in Brazil.
Anselmo-Lima WT; Tamashiro E; Romano FR; Miyake MM; Roithmann R; Kosugi EM; Nakanishi M; Fornazieri MA; Bezerra TFP; Mello JF; Lessa MM; Voegels RL; Piltcher OB; Sakano E; Valera FCP
Braz J Otorhinolaryngol; 2022; 88(3):471-480. PubMed ID: 33867274
[TBL] [Abstract][Full Text] [Related]
52. MUC4 impairs the anti-inflammatory effects of corticosteroids in patients with chronic rhinosinusitis with nasal polyps.
Milara J; Morell A; Ballester B; Armengot M; Morcillo E; Cortijo J
J Allergy Clin Immunol; 2017 Mar; 139(3):855-862.e13. PubMed ID: 27639937
[TBL] [Abstract][Full Text] [Related]
53. Allergic Fungal Rhinosinusitis: The Role and Expectations of Biologics.
Luong AU; Chua A; Alim BM; Olsson P; Javer A
J Allergy Clin Immunol Pract; 2022 Dec; 10(12):3156-3162. PubMed ID: 36028212
[TBL] [Abstract][Full Text] [Related]
54. Biologics for severe uncontrolled chronic rhinosinusitis with nasal polyps: a change management approach. Consensus of the Joint Committee of Italian Society of Otorhinolaryngology on biologics in rhinology.
De Corso E; Bellocchi G; De Benedetto M; Lombardo N; Macchi A; Malvezzi L; Motta G; Pagella F; Vicini C; Passali D
Acta Otorhinolaryngol Ital; 2022 Feb; 42(1):1-16. PubMed ID: 34297014
[TBL] [Abstract][Full Text] [Related]
55. Th2 cytokines orchestrate the secretion of MUC5AC and MUC5B in IL-5-positive chronic rhinosinusitis with nasal polyps.
Zhang Y; Derycke L; Holtappels G; Wang XD; Zhang L; Bachert C; Zhang N
Allergy; 2019 Jan; 74(1):131-140. PubMed ID: 29802623
[TBL] [Abstract][Full Text] [Related]
56. Latest advances in chronic rhinosinusitis with nasal polyps endotyping and biomarkers, and their significance for daily practice.
Maniu AA; Perde-Schrepler MI; Tatomir CB; Tănase MI; Dindelegan MG; Budu VA; Rădeanu GD; Cosgarea M; Mogoantă CA
Rom J Morphol Embryol; 2020; 61(2):309-320. PubMed ID: 33544783
[TBL] [Abstract][Full Text] [Related]
57. EPOS/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023.
Fokkens WJ; Viskens AS; Backer V; Conti D; De Corso E; Gevaert P; Scadding GK; Wagemann M; Bernal-Sprekelsen M; Chaker A; Heffler E; Han JK; Van Staeyen E; Hopkins C; Mullol J; Peters A; Reitsma S; Senior BA; Hellings PW
Rhinology; 2023 Jun; 61(3):194-202. PubMed ID: 36999780
[TBL] [Abstract][Full Text] [Related]
58. The Management of Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) With Biologics.
Wautlet A; Bachert C; Desrosiers M; Hellings PW; Peters AT
J Allergy Clin Immunol Pract; 2023 Sep; 11(9):2642-2651. PubMed ID: 37182568
[TBL] [Abstract][Full Text] [Related]
59. [Biologics: A New Option in Treatment of Severe Chronic Rhinosinusits with Nasal Polyps].
Cuevas M; Zahnert T
Laryngorhinootologie; 2021 Feb; 100(2):134-145. PubMed ID: 33525013
[TBL] [Abstract][Full Text] [Related]
60. [Mechanisms underlying glucocorticoid resistance in chronic rhinosinusitis with nasal polyps].
Zhang YY; Lou HF; Wang CS; Zhang L
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Feb; 53(2):154-160. PubMed ID: 29429191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
